Regulatory Disclosure Summary

Parties Involved

Target Company: Sudeep Pharma Limited

Acquirers/Sellers:

  • Nuvama Crossover Opportunities Fund - Series III (current seller)
  • Nuvama Crossover Opportunities Fund - Series IIIA (current seller)
  • Nuvama Crossover Opportunities Fund - Series IIIB
  • Nuvama Crossover Opportunities Fund - Series IVA

The acquirers do not belong to the Promoter/Promoter group of Sudeep Pharma Limited.

Pre-Disposal Holding Details (Before Sale)

As of the disposal under consideration, the holding of the acquirer along with PACs was:

  • Shares carrying voting rights: 94,51,295 shares (8.4% of total share/voting capital)
  • Total diluted share/voting capital holding: 8.4%

Disposal Details

Shares sold: 26,68,118 equity shares carrying voting rights

Percentage of total share capital: 2.4%

Percentage of total diluted share/voting capital: 2.4%

Mode of sale: Open market transactions

Date of sale: Multiple dates between 15-06-2026 to 24-07-2026

Post-Disposal Holding Details

Remaining shares carrying voting rights: 67,83,177 shares

Percentage of total share capital: 6.0%

Percentage of total diluted share/voting capital: 6.0%

Company Capital Structure

Equity share capital before sale: 11,29,48,625 shares

Equity share capital after sale: 11,29,48,625 shares (unchanged)

Total diluted share/voting capital after acquisition: 11,29,48,625 shares

Additional Context from Acquisition History

From the accompanying Regulation 29(1) disclosure, it is noted that the original acquisition of 94,51,295 shares (8.4% stake) occurred through:

  • Mode of acquisition: Combination of Preferential allotment (for Pre-IPO) and Open market (for IPO)
  • Security features: CCPS converted to equity shares at 1:1 ratio before IPO
  • Acquisition dates: Multiple dates starting from 09-07-2024 (first allotment date) until 27-11-2025 (IPO allotment date)
  • Initial equity capital: As on 09-07-2024: 49,31,850 shares (with subsequent bonus issue, stock split, pre-IPO funding and IPO event)

Stock Exchange Listings

Sudeep Pharma Limited shares are listed on NSE and BSE.